3-(3-chlorophenyl)-N-[(2-piperazin-1-ylphenyl)methyl]pyrazolo[1,5-a]pyrimidine-6-carboxamide;ethane
C28H35ClN6O — CID 142822727
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(3-chlorophenyl)-N-[(2-piperazin-1-ylphenyl)methyl]pyrazolo[1,5-a]pyrimidine-6-carboxamide;ethane
3-(3-chlorophenyl)-N-[(2-piperazin-1-ylphenyl)methyl]pyrazolo[1,5-a]pyrimidine-6-carboxamide;ethane (PubChem CID 142822727) has the molecular formula C28H35ClN6O and a molecular weight of 507.08 g/mol. Its IUPAC name is 3-(3-chlorophenyl)-N-[(2-piperazin-1-ylphenyl)methyl]pyrazolo[1,5-a]pyrimidine-6-carboxamide;ethane.
Molecular Properties
| Compound Name | 3-(3-chlorophenyl)-N-[(2-piperazin-1-ylphenyl)methyl]pyrazolo[1,5-a]pyrimidine-6-carboxamide;ethane |
|---|---|
| PubChem CID | 142822727 |
| Molecular Formula | C28H35ClN6O |
| Molecular Weight | 507.08 g/mol |
| Exact Mass | 506.26 |
| IUPAC Name | 3-(3-chlorophenyl)-N-[(2-piperazin-1-ylphenyl)methyl]pyrazolo[1,5-a]pyrimidine-6-carboxamide;ethane |
| SMILES | CC.CC.O=C(NCc1ccccc1N1CCNCC1)c1cnc2c(-c3cccc(Cl)c3)cnn2c1 |
| InChI | InChI=1S/C24H23ClN6O.2C2H6/c25-20-6-3-5-17(12-20)21-15-29-31-16-19(14-27-23(21)31)24(32)28-13-18-4-1-2-7-22(18)30-10-8-26-9-11-30;2*1-2/h1-7,12,14-16,26H,8-11,13H2,(H,28,32);2*1-2H3 |
| InChIKey | WWPDTIVTSKXMNZ-UHFFFAOYSA-N |
| XLogP | 5.44 |
| TPSA | 74.56 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 507.08 |
| LogP ≤ 5 | 5.44 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142822727 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.